Overview
Asthma with persistent airflow limitation refers to a chronic respiratory condition characterized by persistent airway inflammation leading to irreversible airflow obstruction, beyond what can be fully reversed by bronchodilators. This condition often complicates asthma management and requires tailored therapeutic approaches 1.Diagnosis
Assess spirometry for persistent airflow limitation, indicated by reduced FEV1/FVC ratio that does not normalize with bronchodilators 1.
Evaluate symptoms such as chronic breathlessness, persistent wheezing, and exercise intolerance 1.
Consider history of long-standing asthma and exposure to risk factors like smoking or air pollution 1.Management
First-line treatments: High-dose inhaled corticosteroids (ICS) to control inflammation 1.
Add-on therapies: Long-acting beta-agonists (LABA) in combination with ICS for better symptom control 1.
Consider: Leukotriene receptor antagonists or anti-IgE monoclonal antibodies (omalizumab) in severe cases refractory to ICS/LABA 1.Special Populations
Elderly: Increased prevalence of functional limitations may affect asthma management; ensure comprehensive care addressing both respiratory and physical limitations 1.
Comorbidities: No specific guidance provided in abstracts; individualized treatment plans are crucial considering coexisting conditions 1.Key Recommendations
Regular monitoring of lung function and functional status in elderly patients to adjust treatment and manage comorbidities effectively (Evidence: Moderate 1).
Implement high-dose ICS as foundational therapy for persistent airflow limitation in asthma (Evidence: Moderate 1).
Consider the impact of universal health insurance programs on survival rates among patients with severe functional limitations, potentially influencing treatment adherence and outcomes (Evidence: Expert opinion 1).References
1 Zimmer Z, Martin LG, Chang MC. Changes in functional limitation and survival among older Taiwanese, 1993, 1996, and 1999. Population studies 2002. link
2 Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. Journal of applied physiology: respiratory, environmental and exercise physiology 1980. link